4,929
Views
1
CrossRef citations to date
0
Altmetric
Review

Understanding and Optimizing Ocular Biometry for Cataract Surgery in Dry Eye Disease: A Review

&
Pages 24-30 | Received 09 Feb 2022, Accepted 09 Feb 2022, Published online: 20 Aug 2022

References

  • Gupta P, Drinkwater O, VanDusen K, Brissette A, Starr C. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg. 2018;44(9):1090–1096. doi:10.1016/j.jcrs.2018.06.026.
  • Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the Beaver Dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthal. 2014;157:799–806. doi:10.1016/j.ajo.2013.12.023.
  • Stapleton F, Alves M, Bunya VY, et al. TFOSDEWS II epidemiology report. Ocul Surf. 2017;15:334–365. doi:10.1016/j.jtos.2017.05.003.
  • Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: ocular surface disease index based cross-sectional hospital study. Indian J Ophthal. 2018;66:207–211. doi:10.4103/ijo.IJO_698_17.
  • Donthineni PR, Kammari P, Shanbhag SS, Singh V, Das AV, Basu S. Incidence, demographics, types and risk factors of dry eye disease in India: electronic medical records driven big data analytics I. Ocul Surf. 2019 Apr;17(2):250–256. doi:10.1016/j.jtos.2019.02.007.
  • Craig J, Nichols K, Akpek E, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008.
  • Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412. 28. doi:10.2147/OPTH.S5555.
  • The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop. Ocul Surf. 2007;5(2):93–107. doi:10.1016/S1542-0124(12)70082-4.
  • Miljanovic B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409–415. doi:10.1016/j.ajo.2006.11.060.
  • Li M, Gong L, Chapin WJ, et al. Assessment of vision related quality of life in dry eye patient. Invest Ophthalmol Vis Sci. 2012;53:5722–5727. doi:10.1167/iovs.11-9094.
  • Willcox M, Argueso P, Georgiev G, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15(3):366–403. doi:10.1016/j.jtos.2017.03.006.
  • Koh S. Irregular astigmatism and higher-order aberrations in eyes with dry eye disease. Invest Ophthalmol Vis Sci. 2018;59(14):DES36–DES40. doi:10.1167/iovs.17-23500.
  • Epitropoulos AT, Matossian C, Berdy GJ, et al. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg. 2015;41(8):1672–1677. doi:10.1016/j.jcrs.2015.01.016.
  • Koh S, Tung C, Inoue Y, et al. Effects of tear film dynamics on quality of vision. Br J Ophthalmol. 2018;102(12):1615–1620. doi:10.1136/bjophthalmol-2018-312333.
  • Day AC, Donachie PHJ, Sparrow JM, et al. The royal college of ophthalmologists’ national ophthalmology database study of cataract surgery: report 1, visual outcomes and complications. Eye. 2015;29:552–560. doi:10.1038/eye.2015.3.
  • Addisu Z, Solomon B. Patients’ preoperative expectation and outcome of cataract surgery at Jimma University specialized hospital – department of ophthalmology. Ethiop J Health Sci. 2011;21:47–55. doi:10.4314/ejhs.v21i1.69044.
  • Pager CK. Expectations and outcomes in cataract surgery: a prospective test of 2 models of satisfaction. Arch Ophthalmol. 2004;122:1788–1792. doi:10.1001/archopht.122.12.1788.
  • Craig J, Muntz A, Wang M, et al. Developing evidence-based guidance for the treatment of drye eye disease with artificial tear supplements: a six-month multicentre, double masked randomised controlled trial. Ocul Surf. 2021;20:62–69. doi:10.1016/j.jtos.2020.12.006.
  • Trattler W, Majmudar P, Donnenfeld E, McDonald M, Stonecipher K, Goldberg D. The prospective health assessment of cataract patients’ ocular surface (PHACO) study: the effect of dry eye. Clin Ophthalmol. 2017;11:1423–1430. doi:10.2147/OPTH.S120159.
  • Cochener B, Cassan A, Omiel L. Prevalence of meibomian gland dysfunction at the time of cataract surgery. J Cataract Refract Surg. 2018;44:144–148.
  • Dasgupta S, Gupta R. The course of dry eye following phacoemulsification and manual-SICS: a prospective study based on Indian scenario. Int Eye Sci. 2016;16:17891794.
  • Choi YJ, Park SY, Jun I, et al. Perioperative ocular parameters associated with persistent dry eye symptoms after cataract surgery. Cornea. 2018;37(6):734–739. doi:10.1097/ICO.0000000000001572.
  • Kim J, Kim M, Ha Y, Paik H, Kim D. Improved accuracy of intraocular lens power calculation by preoperative management of dry eye disease. BMC Ophthalmol. 2021; 21(1): doi: 10.1186/s12886-021-02129-5.
  • Klyce SD. Computer-assisted corneal topography. High-resolution graphic presentation and analysis of keratoscopy. Invest Ophthalmol Vis Sci. 1984;25:1426–1435.
  • Goto T, Zheng X, Klyce SD, et al. A new method for tear film stability analysis using videokeratography. Am J Ophthalmol. 2003;135:607–612. doi:10.1016/S0002-9394(02)02221-3.
  • Cronje-Dunn S, Harris WF. Keratometric variation: the influence of a fluid layer. Ophthalmic Physiol Opt. 1996;16:234–236. doi:10.1046/j.1475-1313.1996.95001174.x.
  • Chen S, Wang IJ. Effect of tear film stability on fluctuation of vision after photorefractive keratectomy. J Refract Surg. 1999;15:668–672. doi:10.3928/1081-597X-19991101-11.
  • Buehren T, Collins MJ, Iskander DR, et al. The stability of corneal topography in the post-blink interval. Cornea. 2001;20:826–833. doi:10.1097/00003226-200111000-00010.
  • Liu Z, Pflugfelder S. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology. 1999;106:939–943. doi:10.1016/S0161-6420(99)00513-8.
  • Huang FC, Tseng SH, Shih MH, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology. 2002;109:1934–1940. doi:10.1016/S0161-6420(02)01136-3.
  • de Paiva Cs, Lindsey JL, Pflugfelder SC. Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology. 2003;110:1102–1109. doi:10.1016/S0161-6420(03)00245-8.
  • Kojima T, Ishida R, Dogru M, et al. A new noninvasive tear stability analysis system for the assessment of dry eyes. Invest Ophthalmol Vis Sci. 2004;45:1369–1374. doi:10.1167/iovs.03-0712.
  • Denoyer A, Rabut G, Baudouin C. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology. 2012;119:1811–1818. doi:10.1016/j.ophtha.2012.03.004.
  • Deschamps N, Ricaud X, Rabut G, et al. The impact of dry eye disease on visual performance while driving. Am J Ophthalmol. 2013;156:18. doi:10.1016/j.ajo.2013.02.019.
  • Koh S, Maeda N, Hirohara Y, et al. Serial measurements of higher-order aberrations after blinking in normal subjects. Invest Ophthalmol Vis Sci. 2006;47:3318–3324. doi:10.1167/iovs.06-0018.
  • Koh S, Maeda N, Hori Y, et al. Effects of suppression of blinking on quality of vision in borderline cases of evaporative dry eye. Cornea. 2008;27:275–278. doi:10.1097/ICO.0b013e31815be9c8.
  • Koh S, Maeda N, Hirohara Y, et al. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci. 2008;49:133–138. doi:10.1167/iovs.07-0762.
  • Kaido M, Matsumoto Y, Shigeno Y, Ishida R, Dogru M, Tsubota K. Corneal fluorescein staining correlates with visual function in dry eye patients. Invest Ophthalmol Vis Sci. 2011;52:9516–9522. doi:10.1167/iovs.11-8412.
  • Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear breakup time is sometimes associated with allergic conjunctivitis. Ophthalmology. 1995;102:302–309. doi:10.1016/S0161-6420(95)31024-X.
  • Kaido M, Ishida R, Dogru M, Tsubota K. The relation of functional visual acuity measurement methodology to tear functions and ocular surface status. Jpn J Ophthalmol. 2011;55:451–459.
  • Shimazaki-Den S, Dogru M, Higa K, Shimazaki J. Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea. 2013;32:1211–1218. doi:10.1097/ICO.0b013e318295a2a5.
  • Koh S, Maeda N, Ikeda C, et al. Ocular forward light scattering and corneal backward light scattering in patients with dry eye. Invest Ophthalmol Vis Sci. 2014;55:6601–6606. doi:10.1167/iovs.14-15125.
  • The Royal College of Ophthalmologists Cataract Surgery Guidelines. [ Online] 2010. Available from http://www.rcophth.ac.uk/core/core-picker/download.asp?id=544&filetitle=Cataract+Surgery+Guidelines+2010. (Accessed 21 September 2013).
  • Kim P, Plugfelder S, Slomovic AR. Top 5 pearls to consider when implanting advanced-technology IOLs in patients with ocular surface disease. Int Ophthalmol Clin. 2012;52(2):51–58. doi:10.1097/IIO.0b013e31824b4504.
  • Roggla V, Leydolt C, Schartmuller D, et al. Influence of artificial teras on keratometric measurements in cataract patients. Am J Ophthalmol. 2021;221:1–8. doi:10.1016/j.ajo.2020.08.024.
  • Hovanesian J, Berdy G, Epitropoulos A, Holladay J. Effect of cyclosporine 0.09% treatment on accuracy of preoperative biometry and higher order aberrations in dry eye patients undergoing cataract surgery. Clin Ophthalmol. 2021;15:3679–3686. doi:10.2147/OPTH.S325659.
  • Hovanesian J, Epitropoulos A, Donnenfeld ED, Holladay JT. The effect of lifitegrast on refractive accuracy and symptoms in dry eye patients undergoing cataract surgery. Clin Ophthalmol. 2020;14:2709–2716. doi:10.2147/OPTH.S264520.
  • Teshigawara T, Meguro A, Mizuki N. Effects of rebamipide on difference in power and axis of corneal astigmatism between two intra-patient keratometric measurements in dry eyes. Ophthalmol Ther. 2021;10:891–904. Online ahead of print. doi:10.1007/s40123-021-00368-9.
  • Dogan A, Gurdal C, Kovlu M. Does dry eye affect repeatability of corneal topography measurements? Turk Oftalmoloji Dergisi. 2018;57–60. doi:10.4274/tjo.10179.
  • Khanal S, Tomlinson A, Esakowitz L, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthalmic Physiol Opt. 2008;28:127–134 4. doi:10.1111/j.1475-1313.2008.00539.x.
  • Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013;8(11):e78657. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827040/pdf/pone.0078657.pdf
  • X-M L, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007;26(suppl 1):S16–S20. doi:10.1097/ICO.0b013e31812f67ca.
  • Cho YK, Kim MS. Dry eye after cataract surgery associated and intraoperative risk factors. Korean J Ophthalmol. 2009;23:65–73. doi:10.3341/kjo.2009.23.2.65.
  • Donthineni PR, Shanbhag SS, Basu S. An evidence-based strategic approach to prevention and treatment of dry eye disease, a modern global epidemic. Healthcare (Basel). 2021 Jan 17;9(1):89.
  • Donthineni PR, Das AV, Shanbhag SS, Basu S. Cataract surgery in dry eye disease: visual outcomes and complications. Front Med (Lausanne). 2020 Oct 7;7:575834. doi:10.3389/fmed.2020.575834.
  • Labetoulle M, Leonardi A, Amrane M, et al. Persistence of efficacy of 0.1% cyclosporin A cationic emulsion in subjects with severe keratitis due to dry eye disease: a nonrandomized open-label extension of the SANSIKA study. Clin Ther. 2018;40:1894–1906. doi:10.1016/j.clinthera.2018.09.012.
  • Holland EJ, Luchs J, Karpecki PM, et al. Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked. Placebo-controlled trial (OPUS-3). Ophthalmology. 2017;124:53–60. doi:10.1016/j.ophtha.2016.09.025.
  • Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15:575–628. doi:10.1016/j.jtos.2017.05.006.
  • Labetoulle M, Baudouin C. From pathogenic considerations to a simplified decision-making schema in dry eye disease. J Fr Ophtalmol. 2013;36:543–547. doi:10.1016/j.jfo.2013.03.005.
  • Labetoulle M, Rousseau A, Baudouin C. Management of dry eye disease to optimize cataract surgery outcomes: two tables for a daily clinical practice. J Fr Ophtalmol. 2019;42(8):907–912. doi:10.1016/j.jfo.2019.03.032.
  • Sheard R. Optimising biometry for best outcomes in cataract surgery. Eye. 2014;28(2):118–125. doi:10.1038/eye.2013.248.
  • Sahin A, Hamrah P. Clinically relevant biometry. Curr Opin Ophthalmol. 2012;23(1):47–53. doi:10.1097/ICU.0b013e32834cd63e.